R K Pharma
RK Pharma Inc is a privately held US-based pharmaceutical group with vertically integrated capabilities spanning API manufacturing, sterile injectable and ophthalmic drug product manufacturing, and US/European commercialization of generic pharmaceuticals, serving over 100 pharmaceutical companies and top-ten global generic firms.
- Company typePrivate
- Founded2003
- HeadquartersPearl River, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What R K Pharma does
RK Pharma Inc is a privately held US-based pharmaceutical group with vertically integrated capabilities spanning active pharmaceutical ingredient (API) manufacturing, sterile injectable and ophthalmic drug product manufacturing, and US/European commercialization. The group's core manufacturing operates from a leased 83,000 sq ft facility at the former Pfizer campus in Pearl River, New York, employing isolator technology with robotic automation, in-line quality inspection systems, and high-potency drug handling capability across four dedicated filling isolators covering powder, liquid, ophthalmic, and combination vial/syringe formats. API supply is anchored by USFDA-approved facilities in Visakhapatnam and Vadodara, India (through wholly-owned subsidiaries Apicore Pharmaceuticals and Aktinos Pharma), serving more than 100 pharmaceutical companies worldwide. Finished drug products are commercialized in the US through Archis Pharma LLC and VGYAAN Pharmaceuticals LLC, and in Europe through Archis Pharma Europe LTD, distributed via major wholesalers, retail chains, hospital chains, and GPOs.
The company pursues a B2B generics model with three principal revenue streams: (1) API supply to over 100 pharmaceutical companies via its Apicore subsidiary, (2) sale of in-house developed generic pharmaceutical products (sterile injectables, sterile ophthalmic and dermal products, and solid oral dosage forms) through its US and European commercial arms, and (3) licensing and manufacturing partnerships — notably an exclusive 505(b)(2) oncology supportive care deal with Zydus Lifesciences and five drug product development agreements with top-ten global generic pharmaceutical companies. Revenue mechanics include contract-based B2B pricing, wholesaler/GPO rebates, chargebacks, and Medicaid rebates. The company explicitly reports a double-digit annual growth rate and is currently scaling via a 2023 PAG-led investment of up to USD 200 million, the 2023 VGYAAN acquisition, and ongoing capacity expansion. Founded around 2003 with key subsidiary Apicore LLC, RK Pharma Inc is led by Executive Chairman Dr. Ravishanker Kovi and President & CEO Dr. George R. Thomas.
R K Pharma firmographics
Firmographics- Name
- R K Pharma
- Legal name
- RK Pharma Inc
- Website
- https://rkpharmainc.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- RK Pharma Inc is a privately held US-based pharmaceutical group with vertically integrated capabilities spanning API manufacturing, sterile injectable and ophthalmic drug product manufacturing, and US/European commercialization of generic pharmaceuticals, serving over 100 pharmaceutical companies and top-ten global generic firms.
- Ownership category
- akta.pro rank
R K Pharma industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro industry
- Generic APIs & Intermediates (Active Ingredients)Small-Molecule API Commercial ManufacturingHealthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing ServicesGMP Scale-Up, Tech Transfer & Process Validation (PPQ)Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing ServicesSpecialty Pharmaceutical DistributorsOphthalmology Pharmaceuticals
Keywords
Where R K Pharma is headquartered
LocationHeadquarters
- HQ city
- Pearl River
- HQ country
- United States
- HQ region
- North America
Offices6 records
Markets served
R K Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Generic pharmaceutical product sales: Sale of high quality and affordable generic pharmaceutical products including injectables, sterile ophthalmic and dermal products, and solid oral dosage forms through Archis Pharma LLC in the US and Archis Pharma Europe LTD in Europe.
- API supply to pharmaceutical companies: RK Pharma supplies APIs to over 100 leading pharmaceutical companies worldwide through its subsidiary Apicore LLC.
- Licensing and manufacturing agreements: Manufacturing and supply of pharmaceutical products under licensing agreements with partners like Zydus for 505(b)(2) products, where RK Pharma manufactures and partner commercializes.
Go-to-market motion2 records
Distribution channels5 records
Marketing channels2 records
R K Pharma product offering
Product offeringCore offering
RK Pharma develops, manufactures, and commercializes high-quality and affordable generic pharmaceutical products including sterile injectables (vials and syringes), sterile ophthalmic and dermal products, and solid oral dosage forms. The company is vertically integrated from active pharmaceutical ingredient (API) manufacturing through finished dosage form production, with distribution in the US via Archis Pharma LLC and in Europe via Archis Pharma Europe LTD. It also supplies APIs to over 100 leading pharmaceutical companies worldwide and offers drug product development and commercialization partnerships with top ten generic pharmaceutical firms.
Product overview
RK Pharma Inc is a vertically integrated pharmaceutical company offering a unified portfolio of generic pharmaceutical products, API manufacturing services, and development partnerships. The core offering centers on manufacturing capabilities at the former Pfizer facility in Pearl River, NY, producing sterile injectables (vials, syringes, ophthalmic), dry powder, and solid oral dosage forms. The company's product portfolio includes Apicore LLC (API manufacturing services), Archis Pharma LLC (US commercial operations), and VGYAAN Pharmaceuticals LLC (acquired front-end capabilities). RK Pharma supplies APIs to over 100 pharmaceutical companies and has five drug product development/manufacturing partnerships with top generic companies. The finished dosage products span multiple therapeutic areas including oncology (Mitomycin, Leuprolide), cardiovascular (Nicardipine), psychiatry (Doxepin, Paliperidone), and trace element supplements.
Differentiator
Problem solved
Functional benefit
Products and services
- Diclofenac Potassium Tablets
Quantifiable outcome
- Double-digit annual growth rate
- +2 more outcomes
Companies that use R K Pharma
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
R K Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
R K Pharma partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Zydus Lifesciences Ltd.coreExclusive licensing and commercialization agreement for a novel 505(b)(2) supportive oncology product for the USA market. RK Pharma will manufacture and supply the product, while Zydus will handle NDA submission and commercialization in the US. Filing expected in 2026.
- VGYAAN Pharmaceuticals LLCcoreAcquired by RK Pharma in June 2023 as part of growth strategy. Added to product portfolio and front-end commercialization capabilities. Combined with Archis Pharma LLC for sales and marketing of RK Pharma group's and in-licensed partner products.
- Industrial Realty GroupminorCommercial real estate owner from whom RK Pharma leased 83,000 square feet at the former Pfizer complex in Pearl River, New York.
Scale indicators6 records
Recent moves7 records
Expansion highlights7 records
R K Pharma competitors and assessment
Company assessmentMarket position
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
R K Pharma social profiles
Digital presenceR K Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
R K Pharma leadership team
Management profileNumber of profiles
Profiles6 records
R K Pharma subsidiaries and ownership
Company hierarchySubsidiaries6 records
R K Pharma funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
R K Pharma M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about R K Pharma
What does R K Pharma do?
RK Pharma develops, manufactures, and commercializes high-quality and affordable generic pharmaceutical products including sterile injectables (vials and syringes), sterile ophthalmic and dermal products, and solid oral dosage forms. The company is vertically integrated from active pharmaceutical ingredient (API) manufacturing through finished dosage form production, with distribution in the US via Archis Pharma LLC and in Europe via Archis Pharma Europe LTD. It also supplies APIs to over 100 leading pharmaceutical companies worldwide and offers drug product development and commercialization partnerships with top ten generic pharmaceutical firms.
Is R K Pharma a public or private company?
R K Pharma is a private company. It is classified as venture growth investor backed and is currently operating.
When was R K Pharma founded?
R K Pharma was founded in 2003. It employs 101 to 250 people.
Where is R K Pharma based?
R K Pharma is headquartered in Pearl River, United States, in the North America region.
How does R K Pharma make money?
Three revenue lines are on record. Generic pharmaceutical product sales are the primary driver. The others are API supply to pharmaceutical companies and licensing and manufacturing agreements.
Does R K Pharma have an API?
No public API is recorded for R K Pharma.
What industry is R K Pharma in?
R K Pharma's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAG, Generic APIs & Intermediates (Active Ingredients), with a secondary code of HLAGAHAB, Small-Molecule API Commercial Manufacturing. Its NAICS code is 3254 and its SIC code is 2834.